肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

乳腺癌脑膜转移模型:体内分子成像表征

A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging

原文发布日期:2018-11-13

英文摘要:

摘要翻译:

原文链接:

文章:

乳腺癌脑膜转移模型:体内分子成像表征

A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging

原文发布日期:2018-11-13

英文摘要:

Meningeal metastasis is a fatal complication of breast cancer which affects 8–15% of patients who experience severe neurological complications of cranial nerves, cerebrum, and spinal cord. Survival once diagnosed is less than 4 months. Currently there is no cure. Aggressive multimodal radiation, intra-CSF, or systemic chemotherapy is palliative. Investigation of urgently needed new treatment modalities is hindered by the lack of suitable animal models to effectively study tumor growth kinetics. We present a model of meningeal metastases where tumor growth and associated neurological symptoms have been characterized over 3 weeks by sequential molecular imaging, tumor growth kinetics, and histopathology. Meningeal metastases were induced by stereotaxic injection of human breast cancer cells (MDA-MB-231-Rluc) into the lateral ventricle. Tumor identified by Gd-MRI and Rluc-bioluminescence depict growth in 3 phases, namely lag, exponential, and plateau phase. Invasive tumor growth was highlighted by changes in contrast distribution in the meninges, ventricle and brain compartments over time where moderate contrast uptake in the early growth phase gave rise to a heavy tumor burden in the base of the brain in the latter phases. Tumor growth was accompanied with debilitating neurological symptoms and change in body mass. Tumor was confirmed by ex vivo histology. The reliability of the model to study novel therapeutics was confirmed by oncolytic virus delivered into the lateral ventricle showed potential for treatment. This effective and reliable model resembles human disease progression and is ideally suited to investigate novel treatments. 

摘要翻译:

脑膜转移是乳腺癌的一种致命并发症,约8-15%的患者会因颅神经、大脑及脊髓受累出现严重神经系统症状。一经确诊,患者生存期通常不足4个月,且目前尚无治愈手段。激进的多模式放疗、脑脊液内化疗或全身性化疗仅能缓解症状。由于缺乏能有效模拟肿瘤生长动力学的合适动物模型,亟需的新治疗方案研究受阻。本研究通过连续分子影像、肿瘤生长动力学和组织病理学分析,构建了可在三周内呈现肿瘤生长轨迹及相关神经系统症状的脑膜转移模型。通过立体定向注射人乳腺癌细胞(MDA-MB-231-Rluc)至侧脑室成功诱导脑膜转移,钆增强MRI和荧光素酶生物发光成像显示肿瘤生长经历三个典型阶段:停滞期、指数生长期和平稳期。随病程进展,脑膜、脑室及脑实质内对比剂分布的变化揭示了侵袭性肿瘤生长模式——早期轻度对比剂摄取逐渐发展为后期脑底部大量肿瘤负荷。肿瘤生长伴随进行性神经系统症状恶化及体重变化,并经离体组织学证实。通过侧脑室注射溶瘤病毒验证该模型用于新疗法研究的可靠性,结果显示其具有治疗潜力。本模型能有效模拟人类疾病进程,为新型治疗方案研究提供了理想平台。

原文链接:

A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……